Raymond James & Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-38,788
| Closed | -$926K | – | 3670 |
|
|
2019
Q4 | $926K | Sell |
38,788
-4,795
| -11% | -$114K | ﹤0.01% | 2307 |
|
|
2019
Q3 | $1.17M | Sell |
43,583
-6,308
| -13% | -$169K | ﹤0.01% | 2103 |
|
|
2019
Q2 | $1.35M | Sell |
49,891
-26,383
| -35% | -$716K | ﹤0.01% | 2032 |
|
|
2019
Q1 | $2.65M | Buy |
76,274
+41,610
| +120% | +$1.44M | ﹤0.01% | 1582 |
|
|
2018
Q4 | $677K | Sell |
34,664
-18,653
| -35% | -$364K | ﹤0.01% | 2329 |
|
|
2018
Q3 | $1.42M | Buy |
53,317
+13,015
| +32% | +$347K | ﹤0.01% | 2022 |
|
|
2018
Q2 | $1.52M | Buy |
40,302
+20,441
| +103% | +$772K | ﹤0.01% | 1942 |
|
|
2018
Q1 | $649K | Buy |
19,861
+11,961
| +151% | +$391K | ﹤0.01% | 2403 |
|
|
2017
Q4 | $385K | Buy |
7,900
+3,330
| +73% | +$162K | ﹤0.01% | 2687 |
|
|
2017
Q3 | $247K | Buy |
+4,570
| New | +$247K | ﹤0.01% | 2892 |
|
|
2016
Q4 | – | Sell |
-10,758
| Closed | -$244K | – | 3218 |
|
|
2016
Q3 | $244K | Buy |
10,758
+1,168
| +12% | +$26.5K | ﹤0.01% | 2735 |
|
|
2016
Q2 | $226K | Buy |
+9,590
| New | +$226K | ﹤0.01% | 2572 |
|
|
2016
Q1 | – | Sell |
-19,947
| Closed | -$1.03M | – | 2877 |
|
|
2015
Q4 | $1.03M | Buy |
+19,947
| New | +$1.03M | ﹤0.01% | 1624 |
|